하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
SEOUL, South Korea – August 21, 2025 – HIRONIC Inc. (CEO: Jinwoo Lee), a leading manufacturer of aesthetic medical devices, announced that its advanced synergy device ‘New Doublo 2.0’ has received certification from the Indonesian Ministry of Health (KEMENKES RI). This certification marks an official entry point into one of Southeast Asia’s fastest-growing beauty device markets.
Indonesia, with a population of over 270 million, is the region’s largest market and is experiencing rapid growth in its middle class. As a result, demand for non-invasive aesthetic treatments and premium devices continues to rise, with the country's medical aesthetic device market expanding at an annual growth rate of 11.5%.
‘New Doublo 2.0’ is a multifunctional platform combining HIFU (High-Intensity Focused Ultrasound), RF (Radio Frequency), and Micro-Needling technologies in one system. This enables clinics to offer diverse skin lifting and tightening procedures with a single device—meeting the growing demand for high-performance, multi-modality solutions in aesthetic practices.
The Indonesian market’s increasing preference for advanced, non-invasive lifting procedures aligns with the value proposition of New Doublo 2.0. By delivering enhanced results and treatment flexibility, the device addresses local customer needs and supports clinics’ efforts to differentiate their services through premium technologies.
CMO Sungho Lee commented, “Indonesia is witnessing a surge in demand for aesthetic devices based on multi-energy platforms. New Doublo 2.0, inheriting the legacy of our globally recognized Doublo series, is uniquely positioned to lead this market. We aim to strengthen our footprint in Indonesia and drive global revenue growth through this differentiated innovation.”
Following this certification, HIRONIC plans to focus its market penetration strategy on premium clinics in major Indonesian cities, positioning ‘New Doublo 2.0’ as a top-tier solution for lifting and complex skin treatments. The company also aims to expedite certifications across other Southeast Asian nations.
Additionally, HIRONIC is set to launch the ‘SYNERJET PRO,’ a next-generation skin booster injector, as part of its broader strategy to reinforce its leadership in the aesthetic medical device industry through continuous technological innovation.
